420 VENTURA PL SAN RAMON, CA 94583 Get Directions
420 VENTURA PL SAN RAMON, CA 94583 Get Directions
Dr. Furtado started his career as a protein biochemist then trained as a molecular virologist. He was a faculty member and CLIA service laboratory director at Northwestern University Medical School in Chicago. He switched to the biotechnology industry working for Applied Biosystems and became adept at translating early ideas and concepts into revenue generating product lines that delight customers and improve human health and safety. In the process he helped establish several business units in the Applied Sciences and Diagnostics areas, lead global R & D teams for product development, managed collaborations globally with academic thought leaders, established partnerships with other companies, participated in acquisitions, published extensively in scientific journals, participated actively in professional organizations, helped write guidance documents for clinical diagnostics and presented for the company at numerous scientific meetings and to other companies. Dr. Furtado was appointed by Secretary Sibelius to the National Biodefense Science Board and is responsible for policy decisions related to situational awareness, biosurveillance and emergency medical countermeasures. Recently, he started Biology for Global Good LLC as a consulting service company and is a consultant to several diagnostic companies that want to define clinically relevant applications for novel technologies. He is passionate about building applications that improve human health & safety.
Dr. Furtado is a highly energetic and motivated individual with long term vision and an established track record for creating a wide spectrum of products that improve the human condition. He is an experienced leader for research programs, product development and customer interactions in the regulated and RUO markets. He has launched multiple, innovative, revenue generating product lines in the Molecular Diagnostics, Genomic Assays and Applied Markets (human identification, bio-threat detection, public safety, food safety, animal health and environmental testing) areas that generated over 500 M in revenue in 2012. He helped establish productive long-term collaborations with a broad range of academic, government, pharmaceutical, biotechnology, and professional organizations leading to generation of intellectual property, product ideas, publications, policy documents and scientific presentation of company programs at meetings and to other business entities.
© Dun & Bradstreet, Inc. 2025. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.